Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo
Takita, M.; Matsumura, T.; Yamamoto, K.; Yamashita, E.; Hosoda, K.; Hamaki, T.; Kusumi, E.
Show abstract
Serological evaluation with SARS-CoV-2 specific IgG antibody will be an alternative way to know the pandemic of novel coronavirus disease (COVID-19) if the capacity for diagnostic PCR test is limited. The point-of-care test to detect SARS-CoV-2 specific IgG antibody in peripheral blood (n =202) was performed in two community clinics in Tokyo, Japan. The overall positive rate of SRAS-CoV-2 IgG antibody was 5.9% (95% confidence interval[CI]: 3.1-10.1). Higher rate was observed for healthcare workers (n =55, 9.1 [3.0-20.0]). The limitation on antibody tests includes low sensitivity and potent cross-reactivity with the previous coronavirus. Robust healthcare policy to efficiently monitor COVID-19 spread is warranted in Tokyo.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: a modelling study 94%
- Clinical Evaluation of a Combo Rapid Antigen Test QuickNavi-Flu+COVID19 Ag for Simultaneous Detection of SARS-CoV-2 and Influenza Viruses 93%
- Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2 93%
Similar papers in this journal
- Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China 94%
- Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan 94%
- Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise ship 93%
Similar papers in this journal
- Quantitative SARS-CoV-2 antibody screening of healthcare workers in the southern part of Kyoto city during the COVID-19 peri-pandemic period 93%
- Basic reproduction number of 2019 Novel Coronavirus Disease in Major Endemic Areas of China: A latent profile analysis 93%
- Epidemiological and Genomic Analysis of SARS-CoV-2 in Ten Patients from a Mid-sized City outside of Hubei, China in the Early Phase of the COVID-19 Outbreak 92%
Similar papers in this journal
- Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China 94%
- Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort study 93%
- SARS-CoV-2 R.1 lineage variants prevailed in Tokyo in March 2021 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.